| __timestamp | Galapagos NV | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 396000000 |
| Thursday, January 1, 2015 | 129714000 | 364000000 |
| Friday, January 1, 2016 | 139574000 | 376000000 |
| Sunday, January 1, 2017 | 218502000 | 382000000 |
| Monday, January 1, 2018 | 322876000 | 432000000 |
| Tuesday, January 1, 2019 | 427320000 | 457000000 |
| Wednesday, January 1, 2020 | 523667000 | 463000000 |
| Friday, January 1, 2021 | 491707000 | 508000000 |
| Saturday, January 1, 2022 | 515083000 | 539000000 |
| Sunday, January 1, 2023 | 241294000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, innovation is the key to staying ahead. Zoetis Inc. and Galapagos NV, two giants in the industry, have shown distinct approaches to research and development (R&D) spending over the past decade. From 2014 to 2023, Zoetis consistently outpaced Galapagos in R&D investment, with an average annual expenditure of approximately 45% more. Notably, in 2023, Zoetis's R&D spending surged to 614 million, marking a 55% increase from 2014, while Galapagos saw a decline to 241 million, a significant drop from its peak in 2020. This trend highlights Zoetis's commitment to innovation, even amidst economic fluctuations. As the industry faces new challenges, understanding these spending patterns offers valuable insights into each company's strategic priorities and potential future breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Novartis AG and Galapagos NV
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Investment: Zoetis Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Galapagos NV
Comparing Innovation Spending: Lantheus Holdings, Inc. and Galapagos NV
Analyzing R&D Budgets: Ligand Pharmaceuticals Incorporated vs Galapagos NV
Iovance Biotherapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Dynavax Technologies Corporation or Galapagos NV: Who Invests More in Innovation?
Galapagos NV or Evotec SE: Who Invests More in Innovation?